54 115

Cited 0 times in

병기 T1 성문암 30예의 임상적 고찰

DC Field Value Language
dc.contributor.author김영호-
dc.date.accessioned2023-07-12T00:23:52Z-
dc.date.available2023-07-12T00:23:52Z-
dc.date.issued1994-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/195068-
dc.description.abstractLaryngeal cancer is one of the most frequent cancers in the head and neck area. Clinical analysis was performed on 30 cases of treated T1 glottic cancer patients. Early glottic cancer occured most frequently in male in their sixties and all were well or moderately well differentiated squamous cell carcinoma. Overall five year survival rate was 81.5% and there was no significant difference between stages or the differentiation of the diseases. Recurrence at the primary site, especially anterior commissure, was common, thus careful pre- and postoperative follow up evaluation is recommended.-
dc.description.statementOfResponsibilityopen-
dc.languageKorean-
dc.publisher대한두경부종양학회-
dc.relation.isPartOfKorean Journal of Head and Neck Oncology(대한두경부종양학술지)-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.title병기 T1 성문암 30예의 임상적 고찰-
dc.title.alternativeClinical Analysis of T1 Glottic Cancer-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Otorhinolaryngology (이비인후과학교실)-
dc.contributor.googleauthor김광문-
dc.contributor.googleauthor김영호-
dc.contributor.googleauthor최홍식-
dc.contributor.googleauthor박성수-
dc.contributor.googleauthor이승문-
dc.contributor.googleauthor김명상-
dc.contributor.googleauthor최옹식-
dc.contributor.localIdA00731-
dc.relation.journalcodeJ04045-
dc.contributor.alternativeNameKim, Young Ho-
dc.contributor.affiliatedAuthor김영호-
dc.citation.volume10-
dc.citation.number2-
dc.citation.startPage178-
dc.citation.endPage184-
dc.identifier.bibliographicCitationKorean Journal of Head and Neck Oncology (대한두경부종양학술지), Vol.10(2) : 178-184, 1994-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Otorhinolaryngology (이비인후과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.